Does NAXITAMAB-GQGK Cause Off label use? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Off label use have been filed in association with NAXITAMAB-GQGK. This represents 9.2% of all adverse event reports for NAXITAMAB-GQGK.
14
Reports of Off label use with NAXITAMAB-GQGK
9.2%
of all NAXITAMAB-GQGK reports
0
Deaths
7
Hospitalizations
How Dangerous Is Off label use From NAXITAMAB-GQGK?
Of the 14 reports, 7 (50.0%) required hospitalization, and 3 (21.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NAXITAMAB-GQGK. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does NAXITAMAB-GQGK Cause?
Hypotension (58)
Pain (53)
Hypertension (29)
Rash (24)
Urticaria (21)
Oxygen saturation decreased (17)
Bronchospasm (14)
Hypoxia (13)
Tachycardia (13)
Abdominal pain (12)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NAXITAMAB-GQGK Alternatives Have Lower Off label use Risk?
NAXITAMAB-GQGK vs NEBIVOLOL
NAXITAMAB-GQGK vs NECITUMUMAB
NAXITAMAB-GQGK vs NEDAPLATIN
NAXITAMAB-GQGK vs NEFAZODONE
NAXITAMAB-GQGK vs NEFOPAM